G protein coupled receptors and uses thereof
CA 2498264 A1 · Owner: Gaitanaris, George A. · Inventors: Vassilatis, Demetri; Pavlova, Maria N.; Hohmann, John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides GPCR polypeptides and polynucleotides recombinant materials, and transgenic mice as well as methods for their , production. The polypeptides and polynucleotides are useful for example, in , methods of diagnosis and treatment of diseases and disorders. The invention also provides methods for identifying compounds (e.g. agonists or antagonists) using the GPCR polypeptides and polynucleotides of the invention and for treating conditions associated with GPCR dysfunction with the GPCR polypeptides, polynucleotides, or identified compounds. The invention also provides diagnostic assays for detecting diseases or disorders associated with inappropriate GPCR …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 9, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 9, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 9, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.